Antibodies
27 June 2014
CHMP recommends EU approval of Roche’s Avastin for platinum-resistant recurrent ovarian cancer20 June 2014
Merrimack Pharmaceuticals to Regain Worldwide Rights to Develop and Commercialize MM-12119 June 2014
MacroGenics Initiates Phase 1 Study of MGD006 for the Treatment of Acute Myeloid Leukemia18 June 2014
Kyowa Hakko Kirin initiates a Phase I Trial of KHK6640 for Alzheimer’s Disease in Europe17 June 2014
ABLYNX’S ANTI-vWF NANOBODY, CAPLACIZUMAB, ACHIEVES CLINICAL PROOF-OF-CONCEPT IN PHASE II TITAN STUDY16 June 2014
ImmunoGen, Inc. Announces Preclinical Findings for IMGN779, a Potential Treatment for Acute Myeloid Leukemia13 June 2014
OncoMed Voluntarily Halts Enrollment and Dosing in Phase 1 Vantictumab and Fzd8-Fc TrialsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports